Literature DB >> 10873293

X-linked Charcot-Marie-Tooth disease and connexin32.

V V Ionasescu1.   

Abstract

We studied 29 families with X-linked dominant CMT (CMTX1) neuropathy. Twenty-five families showed mutations in the coding region of the connexin32 (Cx32) gene. The mutations included five nonsense mutations, 17 missense mutations, two medium size deletions and one insertion. Most missense mutations showed a mild clinical phenotype and slowing of motor nerve conduction velocities. All five nonsense mutations, the larger deletion and the insertion showed severe clinical phenotype. Four CMTX1 families with mild clinical phenotype showed no point mutations of the Cx32 gene coding region. Two mutations of the non-coding region were identified. The first mutation was located in the nerve specific Cx32 promoter, the second mutation was located in the 5' untranslated region of the mRNA. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10873293     DOI: 10.1006/cbir.1998.0387

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Four novel connexin 32 mutations in X-linked Charcot-Marie-Tooth disease with phenotypic variability.

Authors:  G Karadima; M Panas; P Floroskufi; N Kalfakis; D Vassilopoulos
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

Review 2.  The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system.

Authors:  Eliseo A Eugenin; Daniel Basilio; Juan C Sáez; Juan A Orellana; Cedric S Raine; Feliksas Bukauskas; Michael V L Bennett; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-23       Impact factor: 4.147

3.  Exome sequencing allows for rapid gene identification in a Charcot-Marie-Tooth family.

Authors:  Gladys Montenegro; Eric Powell; Jia Huang; Fiorella Speziani; Yvonne J K Edwards; Gary Beecham; William Hulme; Carly Siskind; Jeffery Vance; Michael Shy; Stephan Züchner
Journal:  Ann Neurol       Date:  2011-01-20       Impact factor: 10.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.